drugset / Trial / NCT05583604

Managed Access Programs for AIN457, Secukinumab

NCT05583604 ↗

Expanded access Available Novartis Pharmaceuticals

Summary

The purpose of this registration is to list Managed Access Programs (MAPs) related to AIN457, secukinumab

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Background Secukinumab Monoclonal antibody — —